Total Holdings
51
Portfolio diversification across 51 positions

Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Merck & Co., Inc. | Stock | 8.36% |
| 2 | ![]() | Johnson & Johnson | Stock | 7.88% |
| 3 | ![]() | Bristol-Myers Squibb Company | Stock | 7.41% |
| 4 | ![]() | AbbVie Inc | Stock | 6.44% |
| 5 | ![]() | Pfizer Inc. | Stock | 6.28% |
| 6 | ![]() | Eli Lilly and Company | Stock | 4.48% |
| 7 | ![]() | Cardinal Health, Inc. | Stock | 4.48% |
| 8 | ![]() | Biogen Inc | Stock | 4.18% |
| 9 | ![]() | Regeneron Pharmaceuticals, Inc | Stock | 4.17% |
| 10 | ![]() | Viatris Inc. | Stock | 3.99% |
| 11 | ![]() | Gilead Sciences, Inc. | Stock | 3.88% |
| 12 | ![]() | Amgen Inc. | Stock | 3.75% |
| 13 | ![]() | Vertex Pharmaceuticals Incorporated | Stock | 3.63% |
| 14 | ![]() | United Therapeutics Corporation | Stock | 3.32% |
| 15 | ![]() | Zoetis Inc | Stock | 2.45% |
| 16 | ![]() | Jazz Pharmaceuticals plc | Stock | 2.28% |
| 17 | ![]() | Illumina, Inc | Stock | 2.20% |
| 18 | ![]() | PTC Therapeutics, Inc | Stock | 1.66% |
| 19 | ![]() | Incyte Corporation | Stock | 1.62% |
| 20 | ![]() | Charles River Laboratories International, Inc | Stock | 1.60% |
| 21 | ![]() | Exelixis, Inc | Stock | 1.33% |
| 22 | ![]() | Arrowhead Pharmaceuticals, Inc | Stock | 1.21% |
| 23 | ![]() | Medpace Holdings, Inc | Stock | 1.21% |
| 24 | ![]() | Elanco Animal Health Incorporated | Stock | 1.11% |
| 25 | ![]() | BioMarin Pharmaceutical Inc | Stock | 1.07% |
| 26 | ![]() | Halozyme Therapeutics, Inc | Stock | 0.83% |
| 27 | ![]() | Ionis Pharmaceuticals, Inc | Stock | 0.79% |
| 28 | ![]() | Alkermes plc | Stock | 0.76% |
| 29 | ![]() | Amneal Pharmaceuticals, Inc | Stock | 0.75% |
| 30 | ![]() | Krystal Biotech, Inc | Stock | 0.69% |
| 31 | ![]() | Guardant Health, Inc | Stock | 0.66% |
| 32 | ![]() | Neurocrine Biosciences, Inc | Stock | 0.64% |
| 33 | ![]() | BridgeBio Pharma, Inc | Stock | 0.59% |
| 34 | ![]() | Protagonist Therapeutics Inc | Stock | 0.56% |
| 35 | ![]() | Madrigal Pharmaceuticals, Inc | Stock | 0.52% |
| 36 | ![]() | Insmed Incorporated | Stock | 0.52% |
| 37 | ![]() | Ligand Pharmaceuticals Incorporated | Stock | 0.51% |
| 38 | ![]() | Supernus Pharmaceuticals, Inc | Stock | 0.47% |
| 39 | ![]() | Catalyst Pharmaceuticals Inc | Stock | 0.46% |
| 40 | ![]() | Mirum Pharmaceuticals Inc | Stock | 0.45% |
| 41 | ![]() | ADMA Biologics, Inc | Stock | 0.43% |
| 42 | ![]() | TG Therapeutics, Inc | Stock | 0.43% |
| 43 | ![]() | ACADIA Pharmaceuticals Inc | Stock | 0.43% |
| 44 | ![]() | Prestige Consumer Healthcare Inc | Stock | 0.41% |
| 45 | ![]() | Rhythm Pharmaceuticals, Inc | Stock | 0.39% |
| 46 | ![]() | Tempus AI, Inc. Class A Common Stock | Stock | 0.37% |
| 47 | ![]() | Alnylam Pharmaceuticals, Inc | Stock | 0.37% |
| 48 | ![]() | Perrigo Company plc | Stock | 0.33% |
| 49 | ![]() | Corcept Therapeutics Incorporated | Stock | 0.22% |